内镜鼻窦手术后阿片类药物使用的影响因素
该单机构回顾性研究纳入2016年9月至2017年12月接受功能性内镜鼻窦手术(FESS)的136例患者,排除术前使用阿片类药物者,按术后第一周服用阿片类药片数分为三组。多因素分析显示,合并鼻中隔成形术(OR 4.84,95%CI 1.68-13.98,P<.01)和较年轻年龄(OR 0.96,95%CI 0.93-0.99,P=.01)与服用超过5片阿片类药物显著相关。
要点
- 136例FESS患者中,术后第一周23%未用阿片类,45%用1-5片,32%用超过5片。
- 合并鼻中隔成形术者服用超过5片的比值比为4.84(95%CI 1.68-13.98,P<.01)。
- 较年轻年龄与服用超过5片相关(OR 0.96,95%CI 0.93-0.99,P=.01)。
核心结论
- 多数接受FESS的患者术后服用阿片类药物不超过5片。
- 合并鼻中隔成形术和较年轻年龄与阿片类药物使用增加相关。
- 了解这些因素可帮助外科医生评估阿片类药物处方模式并向患者提供术后疼痛咨询。
研究设计与样本
- 单机构回顾性病历研究,纳入2016年9月至2017年12月由资深作者行FESS的患者,排除术前使用阿片类药物者,共136例。
主要发现
- 136例患者按术后第一周服用阿片类药片数分为三组:31例(23%)未服用,61例(45%)服用1-5片,44例(32%)服用超过5片。
- 性别、手术范围、修正手术、息肉状态和囊性纤维化在三组间无显著差异。
- 多因素logistic回归显示,合并鼻中隔成形术者服用超过5片的比值比为4.84(95%CI 1.68-13.98,P<.01)。
- 较年轻年龄与服用超过5片相关(OR 0.96,95%CI 0.93-0.99,P=.01)。
临床怎么用
- 作者认为,了解合并鼻中隔成形术和较年轻年龄等因素有助于外科医生评估阿片类药物处方模式并向患者提供术后疼痛咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Responsible prescribing of postoperative pain medications is necessary in combatting the current opioid epidemic in the United States. The goal of this study was to determine which clinical factors affect opioid usage following functional endoscopic sinus surgery (FESS). STUDY DESIGN: Retrospective medical records study. METHODS: This is a single-institution retrospective study of subjects undergoing FESS by the senior author between September 2016 and December 2017. Opioid usage was assessed for each patient at the first postoperative visit. Univariate and multivariable analyses were performed to investigate factors associated with pain medication usage. Patients using opioids prior to surgery were excluded. RESULTS: A total of 136 patients were stratified into three groups based on number of opioid tablets taken during the first week after surgery: 31 patients (23%) took no opioids, 61 patients (45%) took one to five tablets, and 44 patients (32%) took more than five tablets. Gender, extent of surgery, revision surgery, polyp status, and cystic fibrosis did not significantly vary between the three groups. Multinomial logistic regression analysis with backward stepwise variable selection method revealed that those who had septoplasty (odds ratio [OR]: 4.84, 95% confidence interval [CI]: 1.68-13.98; P < .01) or were of younger age (OR 0.96, 95% CI: 0.93-0.99; P = .01) had significantly higher odds of taking >5 tablets. CONCLUSIONS: The majority of patients undergoing FESS did not take more than 5 opioid tablets after surgery. Concurrent septoplasty and younger age were associated with increased opioid usage. Knowledge of such factors can help surgeons to assess opioid prescribing patterns and to counsel their patients on postoperative pain. Laryngoscope, 129:1751-1755, 2019.
引用
- Raikundalia MD, Cheng TZ, Truong T, et al. Factors associated with opioid use after endoscopic sinus surgery. Laryngoscope. 2019. PMID: 30861579. doi:10.1002/lary.27921
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。